GlassScriptPhysician profile
Seth C Palmer
NPI 1265697783
$3,333.13
in general payments reported to CMS, 2019-2025
19 companies · $939 in 2025
The $939 reported for 2025 was more than what 80% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $548 · 2021: $221 · 2022: $247 · 2023: $351 · 2024: $540 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $619.17 | 2019-2025 | Scopis Ent |
| Integra Lifesciences Corporation | $446.55 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $440.75 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $391.26 | 2019-2024 | |
| Acclarent, INC | $324.40 | 2019-2023 | Trudi Nav Cable, Acclarent Aera, Relieva Spinplus |
| Intersect Ent, INC. | $220.60 | 2019-2021 | |
| Genzyme Corporation | $203.31 | 2021-2025 | |
| Neurent Medical Limited | $166.64 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Medtronic, INC. | $165.40 | 2025 | Nuvent |
| Inspire Medical Systems, INC. | $71.59 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $68.59 | 2021-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $59.99 | 2022 | |
| Optinose US, INC. | $36.09 | 2019-2022 | |
| Ars Pharmaceuticals Operations, INC. | $33.52 | 2025 | Neffy |
| Fortovia Therapeutics, INC. | $25.04 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $16.96 | 2019 | |
| Precigen, INC. | $15.77 | 2025 | |
| Kaleo, INC. | $14.93 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.